Roctavian’s Durability: For The Price, Payers Wanted Longer-Term Proof Anyway

 
• By Cathy Kelly
  
Helix
Payers Begin To Navigate Gene Therapy For Hemophilia A
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet